目录号 | 产品详情 | 靶点 | |
---|---|---|---|
T2633 | ROCK | ||
GSK429286A (RHO-15) 是一种选择性ROCK1/2抑制剂,IC50值为14 和 63 nM。 | |||
T79077 | ROCK | ||
ROCK-IN-6为一有效的ROCK2抑制剂,其IC50值为2.19 nM。该化合物具备用于研究青光眼及视网膜疾病的潜力。 | |||
T7885 | ROCK Akt PKC | ||
Afuresertib hydrochloride 是一个口服有效的,ATP 竞争性的选择性泛Akt 抑制剂,作用于Akt1、Akt2和Akt3,Ki 值分别为 0.08、2和 2.6 nM。 | |||
T1870 | ROCK Apoptosis | ||
Y-27632 是一种 ROCK-I 和 ROCK-II 抑制剂,具有口服有效性、ATP 竞争性。Y-27632 还抑制分离诱导的小鼠前列腺干或祖细胞凋亡。 | |||
T79809 | ROCK | ||
ROCK-IN-8 (Example 4) 是ROCK抑制剂,IC50值不足100 nM,并显示出抗炎活性,适用于呼吸系统和胃肠道疾病的研究。 | |||
T4488 | ROCK S6 Kinase mTOR | ||
GSK-25 是一种选择性的,具有口服活性的 ROCK1抑制剂。它对 31 种激酶以及 RSK1 和 p70S6K 保持良好的选择性,RSK1的 IC50 为 398 nM,p70S6K 的 IC50 为 1000nM。它可抑制 P450,对 CYP2C9、CYP2D6和 CYP3A4的 IC50分别为2.5、5.2和2.5 μM。 | |||
T1898 | ROCK | ||
RKI-1447 是一种高效的ROCK1和ROCK2的小分子抑制剂,IC50值分别为14.5和6.2 nM。 | |||
TQ0187 | ROCK Autophagy | ||
SR-3677 是一种有效且特异性的 ROCK2 抑制剂,IC50值为3 nM。 | |||
T79905 | ROCK | ||
Akt/ROCK-IN-1 (B12) 是Akt和ROCK的双重抑制剂,IC50值分别为0.023 nM和1.47 nM。该化合物对神经母细胞瘤表现出抗肿瘤活性。 | |||
T70935 | |||
Phenoxan is isolated from Polyangium; inhibits electron transport at NADH-ubiquinone oxidoreductase. |
目录号 | 产品名/同用名 | 种属 | 表达系统 | ||
---|---|---|---|---|---|
TMPH-03265 | CMKLR2 Protein, Rat, Recombinant (His) | Rat | in vitro E. coli expression system | ||
Receptor for chemoattractant adipokine chemerin/RARRES2 suggesting a role for this receptor in the regulation of inflammation and energy homesotasis. Signals mainly via beta-arrestin pathway. Binding of RARRES2 activates weakly G proteins, calcium mobilization and MAPK1/MAPK3 (ERK1/2) phosphorylation too. Acts also as a receptor for TAFA1, mediates its effects on neuronal stem-cell proliferation and differentiation via the activation of ROCK/ERK and ROCK/STAT3 signaling pathway.
|
|||||
TMPH-01805 | ODAM Protein, Human, Recombinant (His) | Human | E. coli | ||
Tooth-associated epithelia protein that probably plays a role in odontogenesis, the complex process that results in the initiation and generation of the tooth. May be incorporated in the enamel matrix at the end of mineralization process. Involved in the induction of RHOA activity via interaction with ARHGEF and expression of downstream factors such as ROCK. Plays a role in attachment of the junctional epithelium to the tooth surface.
|
|||||
TMPH-02697 | GNA12 Protein, Mouse, Recombinant (His & Myc) | Mouse | E. coli | ||
Guanine nucleotide-binding proteins (G proteins) are involved as modulators or transducers in various transmembrane signaling systems. Activates effector molecule RhoA by binding and activating RhoGEFs (ARHGEF12/LARG). GNA12-dependent Rho signaling subsequently regulates transcription factor AP-1 (activating protein-1). GNA12-dependent Rho signaling also regulates protein phosphatese 2A activation causing dephosphorylation of its target proteins. Promotes tumor cell invasion and metastasis by activating RhoA/ROCK signaling pathway and up-regulating proinflammatory cytokine production. Inhibits CDH1-mediated cell adhesion in process independent from Rho activation. Together with NAPA promotes CDH5 localization to plasma membrane. May play a role in the control of cell migration through the TOR signaling cascade.
|